The health-related quality of life in patients with prostate cancer managed with active surveillance using the Expanded Prostate Cancer Index Composite survey: Systematic review and meta-analysis

References

• Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6:e1000097.
   PubMed Web of Science ®Google Scholar
• Cancer Research UK. Prostate cancer statistics. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer#heading-Zero
   Google Scholar
• Donovan JL, Hamdy FC, Lane JA, et al. Patient-reported outcomes after monitoring, surgery or radiotherapy for prostate cancer. N Engl J Med. 2016;375:1425–1437.
   PubMed Web of Science ®Google Scholar
• Sanda MG, Dunn RL, Michalski J, et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med. 2008;358:1250–1261.
   PubMed Web of Science ®Google Scholar
• Dasgupta P, Davis J, Hughes S. NICE guidelines on prostate cancer 2019. BJU Int. 2019;124:1.
   PubMed Web of Science ®Google Scholar
• Walton Diaz A, Shakir NA, George AK, et al. Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance. Urol Oncol. 2015;33(5):202-e1– 202.e7.
   Google Scholar
• Acar C, Schoffelmeer C, Tillier C, et al. Quality of life in patients with low-risk prostate cancer. A comparative retrospective study: brachytherapy versus robot assisted laparoscopic prostatectomy versus active surveillance. J Endourol. 2014;28:117–124.
   PubMed Web of Science ®Google Scholar
• Cooperberg MR, Carroll PR. Trends in management for patients with localized prostate cancer, 1990–2013. JAMA. 2015;314(1):80–82.
   PubMed Web of Science ®Google Scholar
• Jeldres C, Cullen J, Hurwitz LM, et al. Prospective quality-of-life outcomes for low-risk prostate cancer: active surveillance versus radical prostatectomy. Cancer. 2015;121:2465–2473.
   Web of Science ®Google Scholar
• Wilcox CB, Gilbourd D, Louie-Johnsun M. Anxiety and health related quality of life (HRQL) in patients undergoing active surveillance of prostate cancer in an Australian centre. BJU Int. 2014;113:64–68.
   PubMed Web of Science ®Google Scholar
• Sureda A, Fumadó L, Ferrer M, et al. Health-related quality of life in men with prostate cancer undergoing active surveillance versus radical prostatectomy, external-beam radiotherapy, prostate brachytherapy and reference population: a cross-sectional study. Health Qual Life Outcomes. 2019;17(1):11.
   Google Scholar
• Wei JT, Dunn RL, Litwin MS, et al. Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer. Urology. 2000;56(6):899–905.
   PubMed Web of Science ®Google Scholar
• Barry MJ, Fowler FJ Jr, O’Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 1992;148:1549–1557.
   PubMed Web of Science ®Google Scholar
• Borghede G, Sullivan M. Measurement of quality of life in localized prostatic cancer patients treated with radiotherapy. Development of a prostate cancer-specific module supplementing the EORTC QLQ-C30. Qual Life Res. 1996;5:212–222.
   PubMed Web of Science ®Google Scholar
• Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993;11:570–579.
   PubMed Web of Science ®Google Scholar
• Esper P, Mo F, Chodak G, et al. Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy-Prostate instrument. Urology. 1997;50:920–928.
   PubMed Web of Science ®Google Scholar
• Litwin MS, Hays RD, Fink A, et al. Quality-of-life outcomes in men treated for localized prostate cancer. JAMA. 1995;273:129–135.
   PubMed Web of Science ®Google Scholar
• Litwin MS, Hays RD, Fink A, et al. The UCLA Prostate Cancer Index: development, reliability, and validity of a health-related quality of life measure. Med Care. 1998;36:1002–1012.
   PubMed Web of Science ®Google Scholar
• McHorney CA, Ware JE Jr, Lu JF, et al. The MOS 36- item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32:40–66.
   PubMed Web of Science ®Google Scholar
• Potosky AL, Harlan LC, Stanford JL, et al. Prostate cancer practice patterns and quality of life: the Prostate Cancer Outcomes Study. J Natl Cancer Inst. 1999;91:1719–1724.
   PubMedGoogle Scholar
• Yarbro CH, Ferrans CE. Quality of life of patients with prostate cancer treated with surgery or radiation therapy. Oncol Nurs Forum. 1998;25:685–693.
   Google Scholar
• Review Manager Web (RevMan Web). The Cochrane Collaboration. 2019. https://revman.cochrane.org/
   Google Scholar
• Parker PA, Davis JW, Latini DM, et al. Relationship between illness uncertainty, anxiety, fear of progression and quality of life in men with favourable‐risk prostate cancer undergoing active surveillance. BJU Int. 2016;117(3):469–477.
   Web of Science ®Google Scholar
• Thompson I, Thrasher JB, Aus G, et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol. 2007;177(6):2106–2131.
   PubMed Web of Science ®Google Scholar
• Venderbos LD, Bokhorst LP, Bangma CH, et al. Active surveillance: oncologic outcome. Curr Opin Urol. 2013;23:268–272.
   Web of Science ®Google Scholar
• Egger SJ, Calopedos RJ, O’Connell DL, et al. Long-term psychological and quality-of-life effects of active surveillance and watchful waiting after diagnosis of low-risk localised prostate cancer. Eur Urol. 2018;73(6):859–867.
   Web of Science ®Google Scholar
• Banerji JS, Hurwitz LM, Cullen J, et al. A prospective study of health-related quality-of-life outcomes for patients with low-risk prostate cancer managed by active surveillance or radiation therapy. Urol Oncol. 2017;35(5):234–242.
   Web of Science ®Google Scholar
• Pham KN, Cullen J, Hurwitz LM, et al. Prospective quality of life in men choosing active surveillance compared to those biopsied but not diagnosed with prostate cancer. J Urol. 2016;196(2):392–398.
   Web of Science ®Google Scholar
• Pearce SM, Wang CH, Victorson DE, et al. A longitudinal study of predictors of sexual dysfunction in men on active surveillance for prostate cancer. Sex Med. 2015;3(3):156–164.
   Web of Science ®Google Scholar
• Cohen A, Lapin B, Wang CH, et al. Variation in testosterone levels and health-related quality of life in men diagnosed with prostate cancer on active surveillance. Urology. 2016;94:180–187.
   Google Scholar
• Korfage IJ, Hak T, de Koning HJ, et al. Patients’ perceptions of the side-effects of prostate cancer treatment–a qualitative interview study. Soc Sci Med. 2006;63(4):911–919.
   Web of Science ®Google Scholar
• Lepore SJ, Eton DT. Response shifts in prostate cancer patients: an evaluation of suppression and buffer models. In: Schwartz CE, Sprangers MAG, editors. Adaptation to changing health—response shift in quality-of-life research. American Psychological Association; 2000. p. 37–51.
   Google Scholar
• Sprangers MA, Schwartz CE. Integrating response shift into health-related quality of life research: a theoretical model. Soc Sci Med. 1999;48(11):1507–1515.
   PubMed Web of Science ®Google Scholar
• Fujita K, Landis P, McNeil BK, et al. Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance. J Urol. 2009;182:2664–2669.
   PubMed Web of Science ®Google Scholar
• Tuncel A, Kirilmaz U, Nalcacioglu V, et al. The impact of transrectal prostate needle biopsy on sexuality in men and their female partners. Urology. 2008;71:1128–1131.
   Web of Science ®Google Scholar
• Zisman A, Leibovici D, Kleinmann J, et al. The impact of prostate biopsy on patient well-being: a prospective study of pain, anxiety and erectile dysfunction. J Urol. 2001;165:445–454.
   PubMed Web of Science ®Google Scholar